Neutralizing antibodies to herpesvirus type 2 in the blood of women with genital cancer
Andonov, P.; Dundarov, S.; Iurkov, K.; Karag'ozov, I.
Voprosy Onkologii 18(4): 54-58
1972
ISSN/ISBN: 0507-3758 PMID: 4337597 Document Number: 56713
Document emailed within 1 workday
Related Documents
Mast, T.Christopher.; Kierstead, L.; Gupta, S.B.; Nikas, A.A.; Kallas, E.G.; Novitsky, V.; Mbewe, B.; Pitisuttithum, P.; Schechter, M.; Vardas, E.; Wolfe, N.D.; Aste-Amezaga, M.; Casimiro, D.R.; Coplan, P.; Straus, W.L.; Shiver, J.W. 2010: International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials Vaccine 28(4): 950-957Boivin, G.; Hankins, C.; Lapointe, N.; Walmsley, S.; Gaudreau, A.; Forest, P.; Coutlée, F. 2000: Human herpesvirus 8 infection of the genital tract of HIV-seropositive and HIV-seronegative women at risk of sexually transmitted diseases. Canadian Women's HIV Study Group Aids 14(8): 1073-1075
Kaleta, E.F.; Bankowski, R.A. 1972: Production of circulating and cell-bound interferon in chickens by type 1 and type 2 plaque-producing agents of the Cal-1 strain of Marek's disease herpesvirus and herpesvirus of turkeys American Journal of Veterinary Research 33(3): 573-577
Vestergaard, B.F. 1982: A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes Developments in Biological Standardization 52: 95-98
Sun, C.; Zhang, Y.; Feng, L.; Pan, W.; Zhang, M.; Hong, Z.; Ma, X.; Chen, X.; Chen, L. 2011: Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern China Vaccine 29(22): 3837-3841
Hadfield, M.G.; Murray, B.K.; Thomson, T.A.; Young, H.F. 1984: Herpesvirus type 1 serum antibodies and brain tumors in humans Clinical Neuropathology 3(2): 68-71
Donners, H.; Willems, B.; Beirnaert, E.; Colebunders, R.; Davis, D.; van der Groen, G. 2002: Cross-neutralizing antibodies against primary isolates in African women infected with HIV-1 Aids 16(3): 501-503
Polvani, C.; Gasparini, A.; Benatti, U.; DeFlora, A.; Silvestri, S.; Volpini, G.; Nencioni, L. 1991: Murine red blood cells as efficient carriers of three bacterial antigens for the production of specific and neutralizing antibodies Biotechnology and Applied Biochemistry 14(3): 347-356
Hutt, R.; Guajardo, J.E.; Kalter, S.S. 1981: Detection of antibodies to Herpesvirus simiae and Herpesvirus hominis in nonhuman primates Laboratory Animal Science 31(2): 184-189
Adam, E.; Rawls, W.E.; Melnick, J.L. 1974: The association of herpesvirus type 2 infection and cervical cancer Preventive Medicine 3(1): 122-141
Alber, D.G.; Greensill, J.; Killington, R.A.; Stokes, A. 1995: Role of T-cells, virus neutralising antibodies and complement-mediated antibody lysis in the immune response against equine herpesvirus type-1 (EHV-1) infection of C3H (H-2k) and BALB/c (H-2d) mice Research in veterinary science 59(3): 205-213
Derevjanko, T.I.; Ryzhkov, V.V. 2015: Viral Infections: Human Papillomavirus and Genital Herpes type 1 and type 2 as a Cause of Chronic Recurrent Cystitis with Severe Dysuria in Women with Urethral Hypermobility and Hypospadias Urologiia 4: 29-32
Omenda, M.M.; Milligan, C.; Odem-Davis, K.; Nduati, R.; Richardson, B.A.; Lynch, J.; John-Stewart, G.; Overbaugh, J. 2013: Evidence for efficient vertical transfer of maternal HIV-1 envelope-specific neutralizing antibodies but no association of such antibodies with reduced infant infection Journal of Acquired Immune Deficiency Syndromes 64(2): 163-166
Wilks, C.R. 1977: In vitro cytotoxicity of serum and peripheral blood leukocytes for equine herpesvirus type 1-infected target cells American Journal of Veterinary Research 38(1): 117-121
Portolani, M.; Mantovani, G.; Pietrosemoli, P.; Cermelli, C.; Boselli, F. 1987: Antibodies to papillomavirus genus-antigens in women with genital warts Microbiologica 10(3): 271-279
Wofsy, C.B.; Cohen, J.B.; Hauer, L.B.; Padian, N.S.; Michaelis, B.A.; Evans, L.A.; Levy, J.A. 1986: Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus Lancet 1(8480): 527-529
Morgan, E.L.; Ember, J.A.; Sanderson, S.D.; Scholz, W.; Buchner, R.; Ye, R.D.; Hugli, T.E. 1993: Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor Journal of Immunology 151(1): 377-388
Hefzy, E.M.S.andE.M. 2011: The Relationship between Antisperm Antibodies Prevalence and Genital Chlamydia trachomatis Infection in Women with Unexplained Infertility African Journal of Reproductive Health / La Revue Africaine de la Santé Reproductive 15(3): 93-101
Plourde, P.J.; Pepin, J.; Agoki, E.; Ronald, A.R.; Ombette, J.; Tyndall, M.; Cheang, M.; Ndinya-Achola, J.O.; D'Costa, L.J.; Plummer, F.A. 1994: Human immunodeficiency virus type 1 seroconversion in women with genital ulcers Journal of Infectious Diseases 170(2): 313-317
Slomka, M.J. 1996: Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus Communicable Disease Report. Cdr Review 6(3): R41-R45